New Delhi, Aug. 13 -- Lord's Mark Industries Limited says it has received a manufacturing licence for an In Vitro Diagnostic Software (Software as a Medical Device - SaMD) for its Biomescan Analytics Platform provided by the Maharashtra State Licensing Authority. The development comes as India's gut health supplements market enters a high-growth phase, valued at USD 565.51 million in 2025 and projected to reach USD 1,619.56 million by 2034, expanding at a CAGR of 11.07%. With the market expected to grow substantially over the next three years, the company says the licence positions it among early movers in an emerging preventive healthcare opportunity, bringing gut microbiome science closer to mainstream wellness and early health manageme...